Increasing prevalence of common diseases and conditions
such as obesity, diabetes, hypertension, etc., are leading to the risk of
various heart problems. Moreover, the rise in people suffering from high blood
pressure, and valvular heart disease due to the rheumatic fever are some of the
most common risk factors for atrial fibrillation. Along with the
increasing number of people suffering from atrial fibrillation, especially
among the geriatric population. There has been an advancement in diagnoses and
treatment of atrial fibrillation. Researchers and experts are also working
together to find out new technologies to improve early detection and diagnosis
of atrial fibrillation and achieve maximum benefit for atrial fibrillation patients.
However, lack of well-trained physicians and the high cost of treatments are
hampering the atrial fibrillation market growth.
The report has provided a detailed profile of some of the
leading players in the global atrial fibrillation market such as Abbott
Laboratories, Biosense Webster, Inc., Medtronic Plc, MicroPort Scientific
Corporation, Boston Scientific Corporation, Biotronik SE & Co. KG,
CardioFocus, Inc., AtriCure Inc., Koninklijke Philips N.V., and Osypka
AG.
Global Atrial Fibrillation Market to Witness
Robust Growth during the Forecast Period 2017-2026
According to a study by Transparency Market Research
(TMR), the global atrial fibrillation market is expected to witness strong
growth. The market is estimated to register 11.0% CAGR during the forecast
period 2017-2026. The market is also estimated to reach US$ 10,925.1 million
revenue by the end of 2026.
On the basis of product type, the EP ablation catheters
are expected to emerge as the most preferred product in the global atrial
fibrillation market. On the basis of end-user, the market is segmented into
electrophysiology labs, hospitals, and ambulatory surgical center. Among these,
hospitals are expected to be witness impressive growth during the forecast period
2017-2026. By application, EP ablation is expected to witness the highest
growth in the global atrial fibrillation market during the forecast period
2017-2026.
Geographically, the market is segmented on the basis of
North America, Latin America, Europe, Japan, APEJ, and MEA. Europe is expected
to dominate the global atrial fibrillation market during the forecast period
2017-2026. A maximum number of catheter ablation are performed in Germany.
Rise in the Use of Less
Invasive and Advanced Treatment for Atrial Fibrillation
Major hospitals and medical centers are using a less
invasive procedure known as catheter ablation for treating atrial fibrillation.
It also has facilitated quick recovery than the surgery. Meanwhile, the
on-going research is also resulting in more options that can be used by doctors
to perform catheter ablation. A recent study by the researchers at the Klinikum
Coburg and the University of Utah Health also showed that radiofrequency
catheter ablation lowered mortality rates in patients suffering from atrial
fibrillation. Being a highly effective therapy, various additional features are
being added to catheter ablation. For instance, new 3D mapping technology
reduces fluoroscopy time and radiation dose for patients. Moreover, a new 3D
catheter mapping technology allowing real-time device tracking in prerecorded
fluoroscopy was also being used. However, new treatment options including FIRM
ablation, convergent procedure, and watchman device have also been developed
and were successful in minimizing the chances of atrial fibrillation.
Increasing demand for minimally invasive procedures and better imaging is
resulting in the manufacturers investing in research and development for
introducing technologically advanced catheter ablation procedure. Meanwhile,
increasing number of hospitals are also using a combination of both device and
drugs to treat atrial fibrillation.
More Trending Reports by
Transparency Market Research:
About Us
Transparency Market Research (TMR) is a market
intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants, use
proprietary data sources and various tools and techniques to gather, and
analyze information. Our business offerings represent the latest and the most
reliable information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated research report covers a different
sector - such as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These reports
provide in-depth analysis and deep segmentation to possible micro levels. With
wider scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research requirement.
US Office Contact
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
